Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Paul Thompson MD

Paul D. Thompson MD

Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut; Professor of Medicine –Emeritus, University of Connecticut, Storrs, Connecticut

Dr. Paul Thompson is Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut, and Professor of Medicine – Emeritus at the University of Connecticut in Storrs. He previously was Professor of Medicine at the University of Pittsburgh from 1992 to 1997 and on the faculty of Brown University from 1978 to 1992.

He has authored over 500 scientific articles on topics which include: the treatment of cardiovascular risk factors; the effects of exercise training on preventing and treating heart disease; the risk of sudden death during exercise; the effects of statins on muscle function; and genetic factors affecting the exercise response. His past NIH funding includes the Preventive Cardiology Academic Award as well as studies examining the effect of exercise training on HDL metabolism; the effect of testosterone on endothelial function; genetic factors affecting muscle hypertrophy with exercise training; the effects of statins on skeletal muscle strength; the effects of coenzyme Q10 on statin myalgia; and genetic factors increasing the risk of statin myalgia.

Dr. Thompson is the co-editor of the book Exercise and Sports Cardiology and of the book Statin-Associated Muscle Symptoms. He is a past president of the American College of Sports Medicine.

Disclosures

  • Consultant: Legal consultation on exercise-related cardiac events and statin myopathy
  • Research funding: Esperion; Novartis
  • Financial interests: Abbott Labs; CVS; Illumina; Novo-Nordisk; GE Healthcare; Johnson & Johnson; Medtronic; OpSens; scPharmaceuticals; Sarepta; Shockwave Medical

Recent Contributions to PracticeUpdate:

  1. Effect of Statin Therapy on Cognitive Decline and Incident Dementia
  2. High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease
  3. Physical Rehabilitation for Older Patients Hospitalized for Heart Failure
  4. The Physical Activity Paradox in Cardiovascular Disease and All-Cause Mortality
  5. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening
  6. Non-HDL Cholesterol Measured Earlier in Life Associated With Coronary Artery Calcification in Mid-Adulthood
  7. Evaluation for Myocarditis in Competitive Student Athletes Recovering From COVID-19 With Cardiac MRI
  8. Association of Physical Activity Intensity With Mortality
  9. 2020 Top Stories in Cardiology: So, I Guess It Isn’t Always the LDL Receptor
  10. Cardiovascular Benefits of a Mediterranean Diet and Intermittent Fasting

Most Read This Week

Recently Updated